- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 15.81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 15.98M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 13.74M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $2.84M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.41M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $8.79M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $2.41M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $116.68M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $108.17M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.28M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.68M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.64M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.4M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $54.59M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $51.35M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $125.97M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $116.24M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.40 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.40 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $223.03K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $237.02K |
| Net Income | Q1 2026 · Mar 31, 2026 | $6.39M |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.61M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $7.58M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $1.4M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $9.56M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $3.7M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $4.92M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $3.58M |
| Revenue | Q1 2026 · Mar 31, 2026 | $14.48M |
| Revenue | Q1 2026 · Mar 31, 2025 | $7.28M |